Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Incidence of Immune-mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Colorectal Cancer in Individuals With Familial Adenomatous Polyposis, Based on Analysis of the Danish Polyposis Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Oral D/L-3-Hydroxybutyrate stimulates cholecystokinin and insulin secretion and slows gastric emptying in healthy males

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Bilio-enteric flow and plasma concentrations of bile acids after gastric bypass and sleeve gastrectomy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Circadian variations in plasma concentrations of cholecystokinin and gastrin in man

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Increased oral sodium chloride intake in humans amplifies selectively postprandial GLP-1 but not GIP, CCK, and gastrin in plasma

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations
Patients with Zollinger-Ellison syndrome (ZES) are treated by proton pump inhibitors (PPIs) to protect them from severe and potentially lethal peptic complications related to massive gastric acid hypersecretion. We report here on the dangerous consequences of interrupting PPI therapy.
Original languageEnglish
JournalClinical Gastroenterology and Hepatology
Volume10
Issue number2
Pages (from-to)199-202
Number of pages4
ISSN1542-3565
DOIs
Publication statusPublished - 2012

    Research areas

  • Esophageal Stenosis, Humans, Intestinal Perforation, Male, Middle Aged, Proton Pump Inhibitors, Withholding Treatment, Zollinger-Ellison Syndrome

ID: 36789907